Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 603.50
+6.30 (1.05%)
Nov 12, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 126.27 billion as of November 12, 2026. It is the 8,556th most valuable company in the world and the 531st biggest in India. Its market cap has decreased by 16.96% in one year.
Market Cap
126.27B
Enterprise Value
121.79B
Revenue
11.70B
Global Rank
Country Rank
#531 India
PE Ratio
44.93
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 126.27B, an increase of 28.02%. That is a compound annual growth rate of 7.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 126.27B | -10.30% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 600.03B |
| Anthem Biosciences | 539.63B |
| OneSource Specialty Pharma | 185.54B |
| Blue Jet Healthcare | 102.88B |
| Supriya Lifescience | 50.80B |
| Zota Health Care | 44.11B |
| Dishman Carbogen Amcis | 26.20B |
| Panacea Biotec | 22.09B |